There is no known cure for the Ebola virus, but a number of labs have been working on one. The two American relief workers recently flown back from Liberia have been receiving an experimental treatment produced by a company in San Diego.
Another company, Cambridge, Mass.-based Sarepta Therapeutics, also has an experimental drug. The company’s CEO, Chris Garabedian, tells Here & Now’s Robin Young how this treatment would work, and what it takes to get the drug to patients.
Guest
- Chris Garabedian, CEO of Sarepta Therapeutics.
Copyright 2021 NPR. To see more, visit https://www.npr.org. 9(MDAyMjQ1NzYwMDEyMjU5MjA0MjE0Yzg1Mg004))
/